Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
clinical trials
life sciences
national blog main
4
×
amgen
boston blog main
cholesterol
inclisiran
new york
new york blog main
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
biotech
boston top stories
national top stories
pcsk9 inhibitors
praluent
repatha
the medicines co.
alirocumab
bempedoic acid
corticosteroids
data
detroit
detroit blog main
detroit top stories
drugs
esperion therapeutics
evercore isi
evolocumab
ezetimibe
fda
fluoroquinolones
heart attack
joseph swartz
ldl
mark timney
medicines co.
mt sinai hospital
pcsk9
What
cholesterol
drug
lowering
4
×
medicines
4
×
medco
fda
twice
aces
alnylam
announced
approved
based
big
bringing
ceo
clears
closer
combo
data
esperion
esperion’s
evidence
filing
flexible
heart
inched
inclisiran
key
lasting
levels
long
looms
market
meant
medicine
morning
nasdaq
new
nod
open
Language
unset
Current search:
medicines
×
photo
×
" national blog main "
×
lowering
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms